On-Chip Cell Incubator for Simultaneous Observation of Culture with and without Periodic Hydrostatic Pressure

Particle Size-Dependent Component Separation Using Serially Arrayed Micro-Chambers

The purpose of this research was to enable component separation based on simple control of the flow rate. We investigated a method that eliminated the need for a centrifuge and enabled easy component separation on the spot without using a battery. Specifically, we adopted an approach that uses microfluidic devices, which are inexpensive and highly portable, and devised the channel within the fluidic device. The proposed design was a simple series of connection chambers of the same shape, connected via interconnecting channels. In this study, polystyrene particles with different sizes were used, and their behavior was evaluated by experimentally observing the flow in the chamber using a high-speed camera. It was found that the objects with larger particle diameters required more time to pass, whereas the objects with smaller particle diameters flowed in a short time; this implied that the particles with a smaller size could be extracted more rapidly from the outlet. By plotting the trajectories of the particles for each unit of time, the passing speed of the objects with large particle diameters was confirmed to be particularly low. It was also possible to trap the particles within the chamber if the flow rate was below a specific threshold. By applying this property to blood, for instance, we expected plasma components and red blood cells to be extracted first.

Challenges and Possibilities of Cell-Based Tissue-Engineered Vascular Grafts

There is urgent demand for biologically compatible vascular grafts for both adult and pediatric patients. The utility of conventional nonbiodegradable materials is limited because of their thrombogenicity and inability to grow, while autologous vascular grafts involve considerable disadvantages, including the invasive procedures required to obtain these healthy vessels from patients and insufficient availability in patients with systemic atherosclerosis. All of these issues could be overcome by tissue-engineered vascular grafts (TEVGs). A large body of evidence has recently emerged in support of TEVG technologies, introducing diverse cell sources (e.g., somatic cells and stem cells) and novel fabrication methods (e.g., scaffold-guided and self-assembled approaches). Before TEVG can be applied in a clinical setting, however, several aspects of the technology must be improved, such as the feasibility of obtaining cells, their biocompatibility and mechanical properties, and the time needed for fabrication, while the safety of supplemented materials, the patency and nonthrombogenicity of TEVGs, their growth potential, and the long-term influence of implanted TEVGs in the body must be assessed. Although recent advances in TEVG fabrication have yielded promising results, more research is needed to achieve the most feasible methods for generating optimal TEVGs. This article reviews multiple aspects of TEVG fabrication, including mechanical requirements, extracellular matrix components, cell sources, and tissue engineering approaches. The potential of periodic hydrostatic pressurization in the production of scaffold-free TEVGs with optimal elasticity and stiffness is also discussed. In the future, the integration of multiple technologies is expected to enable improved TEVG performance.